Market Snapshot
S&P Futures
3,809.5
Dow Futures
30,868
Nasdaq Futures
11,633.25
Mainz Biomed B.V. (MYNZ) stock declined over -5.61% intraday to trade at $9.25 a share on NASDAQ. The stock opened with a loss of -7.59% at $9.52 and touched an intraday high of $9.74, falling -5.61% against the last close of $9.8. The stock went to a low of $9.25 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-06-30 | $9.52 | $9.74 | $9.25 | $9.25 | 5,903 |
2022-06-29 | $10.01 | $10.245 | $9.5 | $9.8 | 9,500 |
2022-06-28 | $9.92 | $10.5 | $9.92 | $10.15 | 15,300 |
2022-06-27 | $9.9 | $10.31 | $9.86 | $9.86 | 8,000 |
2022-06-24 | $10.15 | $11 | $9.51 | $10.12 | 38,600 |
2022-06-23 | $9.72 | $9.72 | $9.345 | $9.6 | 12,000 |
2022-06-22 | $9.37 | $9.78 | $9.09 | $9.55 | 30,100 |
2022-06-21 | $9.79 | $10.49 | $9.382 | $10.05 | 66,000 |
2022-06-17 | $9.37 | $9.37 | $8.56 | $8.985 | 42,400 |
2022-06-16 | $9.4 | $9.61 | $9.02 | $9.61 | 10,300 |
Employees-
Beta-
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends-
SectorHealth Care
IndustryBiotechnology
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Mainz Biomed B.V. (NASDAQ: MYNZ) stock price is $9.25 as of the last check on Thursday, June 30. During the trading session, MYNZ stock reached the peak price of $9.74 while $9.25 was the lowest point it dropped to.
The NASDAQ listed MYNZ is part of Biotechnology industry that operates in the broader Health Care sector. Mainz Biomed B. V.
Mr. Guido Baechler
CEO & Director
Mr. William J. Caragol
Chief Financial Officer
Mr. Philipp Freese
Chief Operating Officer
Dr. Moritz Eidens Ph.D.
Chief Science Officer & Director
MYNZ stock traded closed the last session at $9.25, which is $-0.55 or -5.61% lower than its previous close of $9.8. MYNZ's current trading price is 18.59% lower than its 52-week high of $30.00 where as its distance from 52-week low of 7.80% is -69.17%.
Number of MYNZ employees currently stands at -. MYNZ operates from Robert Koch Strasse 50, Mainz 55129, Germany.
Official Webiste of $MYNZ is: https://mainzbiomed.com
MYNZ could be contacted at MYNZ operates from Robert Koch Strasse 50, Mainz 55129, Germany, or at phone #49 6131 554 2860 and can also be accessed through its website.
MYNZ stock volume for the day was 5,903 shares while in the previous session number of MYNZ shares traded was 5,903 . The average number of MYNZ shares traded daily for last 3 months was 29.68 Thousands.
The percentage change in MYNZ stock occurred in the recent session was -5.61% while the dollar amount for the price change in MYNZ stock was $-0.55.
In the recent session, the day high for MYNZ stock was $9.74 while the low for MYNZ stock touched on the day was $9.25.
The market value of MYNZ currently stands at 108.32 Million with its latest stock price at $9.25 and 11.71 Million of its shares outstanding.